Drugs / RN3161
last change Nov 2025 re-read 2 minutes ago

RN3161

Developed for
obesity disorder
Investigated by
Ikaria Bioscience Pty Ltd · Shanghai Rona Therapeutics Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT07245771 Nov 2025 → Feb 2027 expected obesity disorder Ikaria Bioscience Pty Ltd Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as RN3161 ClinicalTrials.gov intervention name — accepted as the source's own label NCT07245771